Sotuvning sof marjinal rentabelligi: Pieris Pharmaceuticals (PVLA)

Pieris Pharmaceuticals Inc (PVLA) grafik logotipi

Sof marja tuzilmasi daromadlilik dinamikasini namoyish etadi, bunda ko'rsatkich 0.00 miqdorida qat'iy belgilangan. Pieris Pharmaceuticals (PVLA) saraton terapiyasi uchun innovatsion Anticalin oqsillari orqali narxlarni belgilash imkoniyatini izlamoqda. Kompaniya tashqi testlar va ishlab chiqarishni boshqarish orqali operatsion moslashuvchanlikka erishmoqda. Biroq, joriy naqd pul tanqisligi va sherikliklarning bekor qilinishi Pieris Pharmaceuticals (PVLA) kompaniyasini aktivlarni chuqur restrukturizatsiya qilishga majbur qilmoqda.

Pieris Corp (PVLA) Sof foyda normasi: 04.07.2022 - 20.11.2026 davri uchun

Pieris Pharmaceuticals (PVLA) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning jamlanma tahliliyoti:Pieris Pharmaceuticals
Pieris Corp ishlab chiqargan mahsulot

Sotuv marjalari umumiy daromadning sof foyda ulushini aks ettiradi, bu esa investorlarga xarajatlarni boshqarish samaradorligini va biznesning bozor tebranishlariga chidamliligini baholash imkonini beradi. Daromad marjalini tahlil qilishda shuni ta'kidlash joizki, Pieris Pharmaceuticals (PVLA) uchun asosiy o'sish drayveri immuno-onkologiya va o'pka kasalliklarini davolash segmentlaridagi anticalin proteinlarining tijorat muvaffaqiyati bo'ladi.

Raqobatdosh kompaniyalar

argenx (ARGX) - Sof marja|BNTX - Kompaniya sotuv marjasi|ABVX (Abivax Pharma) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi ADMA Bio (ADMA)|Sof foyda bo'yicha sotuv rentabelligi PTGX (Protagonist Therapeutics Inc)|Sotuvning sof marjinal rentabelligi immunovant.com (IMVT)|Sof marja kiniksa.com KNSA|Grifols SA (GRFS) - Sof marja|Adaptive Biotechnologies Inc. - Sotuvning sof marjinal rentabelligi|Sof marja Celldex Therapeutics|AUPH: Sotuvning sof marjinal rentabelligi|BCRX - Kompaniya sotuv marjasi|VERA (Vera Corp) - Sotuvning sof marjinal rentabelligi|Dianthus Pharma (DNTH) - Kompaniya sotuv marjasi|Sof marja Pharvaris Pharma (PHVS)|Sotuvning sof marjinal rentabelligi AbCellera Corp (ABCL)|Sotuvning sof marjinal rentabelligi TRML (Tourmaline Bio Inc)|Kompaniya sotuv marjasi precigen.com (PGEN)|PHAR - Sof marja|Sof foyda normasi NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Sof foyda bo'yicha sotuv rentabelligi|Zenas Corp (ZBIO) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi IMNM|GOSS: Sof foyda normasi|Sof marja KalVista Pharma (KALV)|SEPN - Sof marja|Sotuvning sof marjinal rentabelligi SVRA (Savara Inc)|Sotuvning sof marjinal rentabelligi Rigel Pharmaceuticals RIGL|AnaptysBio Inc. - Sotuvning sof marjinal rentabelligi|Astria Therapeutics - Kompaniyaning sof rentabelligi|ENGN: Sotuvning sof marjinal rentabelligi|RAPT - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi JBIO|Aclaris (ACRS) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi KYTX|Sof foyda bo'yicha sotuv rentabelligi Tiziana Life Sciences TLSA|Sotuvning sof marjinal rentabelligi CABA (cabalettabio.com)|Kompaniyaning sof rentabelligi VTYX (Ventyx Bio)|Theratechnologies, Inc - Sotuvning sof marjinal rentabelligi|AVTX (Avalo Therapeutics Inc.) - Sotuvning sof rentabelligi|eledon.com (ELDN) - Sof marja|Sotuvning sof rentabelligi AGEN|CLYM (climbbio.com) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi zurabio.com|Sof marja aTyr (ATYR)|ADAG - Sof marja|Sof marja ImageneBio Inc IMA|Sotuvning sof marjinal rentabelligi Shattuck Labs, Inc. STTK|EQ - Sof marja|connectbiopharm.com (CNTB) - Sof foyda bo'yicha sotuv rentabelligi|IMUX (Immunic) - Sof foyda bo'yicha sotuv rentabelligi|Atara Biotherapeutics, Inc. - Sof foyda normasi|Sof marja InflaRx|Sof foyda bo'yicha sotuv rentabelligi x4pharma.com (XFOR)|Sotuvning sof marjinal rentabelligi ACET|Sof foyda bo'yicha sotuv rentabelligi Celularity Corp CELU|INmune Bio Inc - Sof foyda bo'yicha sotuv rentabelligi|BRNS (Barinthus Bio) - Sof foyda marjasi|KZR - Sof marja|Kompaniya sotuv marjasi sabbiotherapeutics.com SABS|Akari Therapeutics PLC (AKTX) - Sof marja|ENLV - Kompaniya sotuv marjasi|QTTB (Q32 Bio) - Sotuvning sof marjinal rentabelligi|Sof marja GeoVax Labs Inc GOVX|Sof marja Edesa Biotech (EDSA)|Sof foyda bo'yicha sotuv rentabelligi iBio IBIO|Carisma Therapeutics Inc - Sof foyda bo'yicha sotuv rentabelligi|XTLB - Sof foyda bo'yicha sotuv rentabelligi|BOLT - Sof marja|Sof foyda normasi HCWB (hcwbiologics.com)|APVO: Sotuvning sof marjinal rentabelligi|aimimmuno.com (AIM) - Sotuvning sof marjinal rentabelligi|Sof marja aditxt.com|Sof foyda bo'yicha sotuv rentabelligi GRI Bio Corp (GRI)|Sof marja XORTX Therapeutics Inc. (XRTX)|Sof foyda bo'yicha sotuv rentabelligi ReShape Lifesciences HIND|Sof marja Revelation Biosciences REVB|INDP: Sotuvning sof rentabelligi|SCNI - Sof marja|CALI (calcimedica.com) - Sotuvning sof rentabelligi|AFMD (Affimed Therapeutics) - Sof foyda bo'yicha sotuv rentabelligi|Allakos Therapeutics (ALLK) - Sotuvning sof marjinal rentabelligi|HOOK (HOOKIPA) - Sotuvning sof marjinal rentabelligi|igmbio.com (IGMS) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi ITOS|OCEA (Ocean Biomedical) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi TCBP (TC BioPharm (Holdings) PLC)|THRD - Sof foyda bo'yicha sotuv rentabelligi